cephalosporin c has been researched along with lopinavir in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, W; Hwang, TH; Jang, J; Jang, SP; Jang, SW; Kim, BO; Park, HW; Park, SK; Park, YK; Shin, J; Yang, W | 1 |
1 other study(ies) available for cephalosporin c and lopinavir
| Article | Year |
|---|---|
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study.
Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cephalosporins; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lopinavir; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome | 2022 |